Published in TB and Outbreaks Week, June 13th, 2006
"In response to the ever-growing threat to public health by infectious diseases, ImmPORT has developed a revolutionary technology that offers a fast and cost-effective platform for developing diagnostics and vaccines," said Dr. Xiaowu Liang, chief technical officer of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week